Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 10 hours agovaccine, Nuvaxovid. Since then, the stock has trended lower. The vaccine is based on protein...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 9 hours agoSmith recommends that “if you do test positive, then you need to talk to a doctor about whether or...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 days agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 4 days agoArexvy had an exceptional launch and generated...GSK expects Arexvy to generate more than £3 billion...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 8 hours agoThe new RSV vaccines approved for older adults may be linked to a slightly increased risk of a rare...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 4 days agoBoth Pfizer-BioNTech and Novavax are studying combination vaccines to protect against COVID-19 and influenza. Moderna: Combination vaccine</ ...